An immunoglobulin G (IgG) antibody capture assay (GACRIA) methodologically distinct from other assays for the detection of antibodies to human T-lymphotropic virus type III/lymphadenopathy-associated virus (anti-HTLV III/LAV) was developed and used to test 1,055 serum samples previously screened by
WHICH ANTI-HTLV III/LAV ASSAYS FOR SCREENING AND CONFIRMATORY TESTING?
β Scribed by Mortimer, P.P.; Parry, J.V.; Mortimer, J.Y.
- Book ID
- 121914531
- Publisher
- The Lancet
- Year
- 1985
- Tongue
- English
- Weight
- 479 KB
- Volume
- 326
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The sensitivity of nine commercial assays, Western blot, and a newly developed monoclonal antibody-based assay for antibody to human T lymphotropic virus type III/lymphoadenopathy associated virus (anti-HTLV III/LAV) were evaluated using a panel of mainly weak-positive sera. In tests on 20 sera thre
## Abstract During an epidemiological study of a low risk U.K. population diverse screening and confirmatory assays for the detection of antiβHTLVβ1/11 were assessed. Sera from 2,900 antenatal patients were tested for antiβHTLVβ1/11 by gelatin particle agglutination assay (GPA). All reactive sera,